{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T11:28:12Z","timestamp":1763724492590,"version":"3.37.3"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,12,2]],"date-time":"2020-12-02T00:00:00Z","timestamp":1606867200000},"content-version":"vor","delay-in-days":1,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Cuiying Graduate Supervior Applicant Training Program of Lanzhou University Second Hospital","award":["201711"],"award-info":[{"award-number":["201711"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pharmacol Toxicol"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Hypertension is the the primary cause of diastolic heart failure. Oxidative stress plays an important role in cardiac diastolic dysfunction caused by hypertension. The occurrence of oxidative stress is related to the level of nitric oxide (NO) in the body. Tetrahydrobiopterin (BH4) is an essential cofactor for NO synthesis. Nebivolol can reduce myocardial oxidative stress and increase NO activity. Therefore, we investigated the effects of monotherapy or combination therapy of different doses of BH4 and nebivolol on cardiac diastolic function in spontaneously hypertensive rats, and preliminarily expounded the related mechanisms.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Left ventricular function was evaluated by\u00a0non-invasive echocardiographic assessment and invasive right carotid artery catheterization methods. ELISA was used to measure myocardial 3-nitrotyrosine content, NO production, and cyclic guanosine monophosphate (cGMP) concentration in the myocardium; quantitative real-time PCR (qRT-PCR) was used to determine endothelial nitric oxide synthase (eNOS), phospholamban and sarcoplasmic reticulum Ca<jats:sup>2+<\/jats:sup>-ATPase 2a (SERCA2a) mRNA expression levels; Western blot was used to detect the protein expression levels of eNOS and eNOS dimers in myocardial tissue, and immunohistochemical detection of cGMP expression in the myocardium was performed.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Studies have shown that compared with those in the control group, NO generation and the expression level of myocardial eNOS mRNA, eNOS expression of dimers, phospholamban, SERCA2a and cGMP increased significantly after the combined intervention of BH4 and nebivolol, while the expression of 3-nitrotyrosine was significantly decreased.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The combined treatment group had a synergistic effect on reducing myocardial oxidative stress, increasing eNOS content, and increasing NO production, and had a more obvious protective effect on diastolic dysfunction through the nitric oxide\/cyclic guanosine monophosphate (NO\/cGMP) pathway.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s40360-020-00460-z","type":"journal-article","created":{"date-parts":[[2020,12,2]],"date-time":"2020-12-02T11:03:45Z","timestamp":1606907025000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Nebivolol combined with tetrahydrobiopterin affects diastolic function in spontaneously hypertensive rats via the nitric oxide\/cyclic guanosine monophosphate signalling pathway"],"prefix":"10.1186","volume":"21","author":[{"given":"Xiaoli","family":"Guan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoying","family":"Guan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Changhong","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Shang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Meng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7076-3773","authenticated-orcid":false,"given":"Zhengyi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,12,2]]},"reference":[{"issue":"9","key":"460_CR1","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1007\/s11906-020-01077-7","volume":"22","author":"JP Kalehoff","year":"2020","unstructured":"Kalehoff JP, Oparil S. The story of the silent killer: a history of hypertension: its discovery, diagnosis, treatment, and debates. Curr Hypertens Rep. 2020;22(9):72.","journal-title":"Curr Hypertens Rep"},{"issue":"1","key":"460_CR2","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1097\/ACO.0000000000000276","volume":"29","author":"A Nicoara","year":"2016","unstructured":"Nicoara A, Jones-Haywood M. Diastolic heart failure: diagnosis and therapy. Curr Opin Anaesthesiol. 2016;29(1):61\u20137.","journal-title":"Curr Opin Anaesthesiol"},{"issue":"3","key":"460_CR3","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1253\/circj.CJ-15-0064","volume":"79","author":"EM Jeong","year":"2015","unstructured":"Jeong EM, Dudley SC Jr. Diastolic dysfunction. Circ J. 2015;79(3):470\u20137.","journal-title":"Circ J"},{"issue":"4","key":"460_CR4","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1093\/cvr\/cvy257","volume":"115","author":"AT Roe","year":"2019","unstructured":"Roe AT, et al. Regional diastolic dysfunction in post-infarction heart failure: role of local mechanical load and SERCA expression. Cardiovasc Res. 2019;115(4):752\u201364.","journal-title":"Cardiovasc Res"},{"key":"460_CR5","doi-asserted-by":"crossref","unstructured":"Trivedi RK, et al. Combined Angiotensin Receptor-Neprilysin Inhibitors Improve Cardiac and Vascular Function Via Increased NO Bioavailability in Heart Failure. J Am Heart Assoc. 2018;7(5):e008268.","DOI":"10.1161\/JAHA.117.008268"},{"issue":"1","key":"460_CR6","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s10741-011-9228-4","volume":"17","author":"D Tousoulis","year":"2012","unstructured":"Tousoulis D, et al. Conflicting effects of nitric oxide and oxidative stress in chronic heart failure: potential therapeutic strategies. Heart Fail Rev. 2012;17(1):65\u201379.","journal-title":"Heart Fail Rev"},{"issue":"4","key":"460_CR7","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1016\/j.bbrc.2015.06.051","volume":"463","author":"P Chang","year":"2015","unstructured":"Chang P, et al. Tetrahydrobiopterin reverse left ventricular hypertrophy and diastolic dysfunction through the PI3K\/p-Akt pathway in spontaneously hypertensive rats. Biochem Biophys Res Commun. 2015;463(4):1012\u201320.","journal-title":"Biochem Biophys Res Commun"},{"issue":"9","key":"460_CR8","first-page":"759","volume":"44","author":"QY Wang","year":"2016","unstructured":"Wang QY, et al. Tetrahydrobiopterin improves left ventricular diastolic function possibly through upregulating phosphorylated protein kinase B expression in hypertensive mice induced by deoxycorticosterone acetate. Zhonghua Xin Xue Guan Bing Za Zhi. 2016;44(9):759\u201365.","journal-title":"Zhonghua Xin Xue Guan Bing Za Zhi"},{"issue":"3","key":"460_CR9","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1111\/bcpt.13248","volume":"125","author":"N Olawi","year":"2019","unstructured":"Olawi N, et al. Nebivolol in the treatment of arterial hypertension. Basic Clin Pharmacol Toxicol. 2019;125(3):189\u2013201.","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"6","key":"460_CR10","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1158\/1541-7786.MCR-15-0057-T","volume":"13","author":"CS Rabender","year":"2015","unstructured":"Rabender CS, et al. The role of nitric oxide synthase uncoupling in tumor progression. Mol Cancer Res. 2015;13(6):1034\u201343.","journal-title":"Mol Cancer Res"},{"key":"460_CR11","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.jchromb.2013.01.009","volume":"919\u2013920","author":"B Maganda","year":"2013","unstructured":"Maganda B, et al. A fast and reliable reversed phase high performance liquid chromatography method for simultaneous determination of selected anti-retroviral and lumefantrine in human plasma. J Chromatogr B Analyt Technol Biomed Life Sci. 2013;919\u2013920:52\u201360.","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"issue":"4","key":"460_CR12","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(\u2212Delta Delta C(T)) method. Methods. 2001;25(4):402\u20138.","journal-title":"Methods"},{"key":"460_CR13","doi-asserted-by":"crossref","unstructured":"Torres-Narv\u00e1ez JC, P\u00e9rez-Torres I. The Role of the Activation of the TRPV1 Receptor and of Nitric Oxide in Changes in Endothelial and Cardiac Function and Biomarker Levels in Hypertensive Rats. Int J Environ Res Public Health. 2019;16(19):3576.","DOI":"10.3390\/ijerph16193576"},{"issue":"1\u20132","key":"460_CR14","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.jchromb.2006.08.054","volume":"851","author":"HM van Eijk","year":"2007","unstructured":"van Eijk HM, et al. Methods using stable isotopes to measure nitric oxide (NO) synthesis in the L-arginine\/NO pathway in health and disease. J Chromatogr B Analyt Technol Biomed Life Sci. 2007;851(1\u20132):172\u201385.","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"issue":"24","key":"460_CR15","first-page":"4872","volume":"19","author":"G Mercanoglu","year":"2015","unstructured":"Mercanoglu G, et al. Nitric oxide mediated effects of nebivolol in myocardial infarction: the source of nitric oxide. Eur Rev Med Pharmacol Sci. 2015;19(24):4872\u201389.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"1","key":"460_CR16","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1038\/s41598-020-57673-9","volume":"10","author":"I Lee","year":"2020","unstructured":"Lee I, et al. CR6-interacting factor 1 deficiency reduces endothelial nitric oxide synthase activity by inhibiting biosynthesis of tetrahydrobiopterin. Sci Rep. 2020;10(1):842.","journal-title":"Sci Rep"},{"issue":"11","key":"460_CR17","doi-asserted-by":"publisher","first-page":"H2341","DOI":"10.1152\/ajpheart.01126.2011","volume":"302","author":"L Ma","year":"2012","unstructured":"Ma L, et al. Nebivolol improves diastolic dysfunction and myocardial remodeling through reductions in oxidative stress in the transgenic (mRen2) rat. Am J Physiol Heart Circ Physiol. 2012;302(11):H2341\u201351.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"5","key":"460_CR18","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.yjmcc.2009.06.005","volume":"47","author":"AL Moens","year":"2009","unstructured":"Moens AL, et al. Adverse ventricular remodeling and exacerbated NOS uncoupling from pressure-overload in mice lacking the beta3-adrenoreceptor. J Mol Cell Cardiol. 2009;47(5):576\u201385.","journal-title":"J Mol Cell Cardiol"},{"issue":"12","key":"460_CR19","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1016\/j.amjhyper.2007.08.007","volume":"20","author":"BM Mitchell","year":"2007","unstructured":"Mitchell BM, et al. Uncoupled endothelial nitric oxide synthase and oxidative stress in a rat model of pregnancy-induced hypertension. Am J Hypertens. 2007;20(12):1297\u2013304.","journal-title":"Am J Hypertens"},{"key":"460_CR20","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.cbi.2017.09.012","volume":"278","author":"R Geetha","year":"2017","unstructured":"Geetha R, et al. Troxerutin abrogates mitochondrial oxidative stress and myocardial apoptosis in mice fed calorie-rich diet. Chem Biol Interact. 2017;278:74\u201383.","journal-title":"Chem Biol Interact"},{"issue":"4","key":"460_CR21","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1007\/s12471-016-0814-x","volume":"24","author":"A Kovacs","year":"2016","unstructured":"Kovacs A, et al. Is enhancing cGMP-PKG signalling a promising therapeutic target for heart failure with preserved ejection fraction? Neth Heart J. 2016;24(4):268\u201374.","journal-title":"Neth Heart J"},{"issue":"2","key":"460_CR22","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.cardiores.2006.02.020","volume":"70","author":"Y Abdallah","year":"2006","unstructured":"Abdallah Y, et al. Insulin protects cardiomyocytes against reoxygenation-induced hypercontracture by a survival pathway targeting SR Ca2+ storage. Cardiovasc Res. 2006;70(2):346\u201353.","journal-title":"Cardiovasc Res"},{"issue":"12","key":"460_CR23","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1161\/CIRCRESAHA.111.259754","volume":"110","author":"EG Kranias","year":"2012","unstructured":"Kranias EG, Hajjar RJ. Modulation of cardiac contractility by the phospholamban\/SERCA2a regulatome. Circ Res. 2012;110(12):1646\u201360.","journal-title":"Circ Res"},{"issue":"1","key":"460_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1385\/CBB:42:1:001","volume":"42","author":"SY Li","year":"2005","unstructured":"Li SY, et al. Inhibition of sarco (endo) plasmic reticulum Ca2+\u2212ATPase differentially regulates contractile function in cardiac myocytes from normotensive and spontaneously hypertensive rats: role of Ca2+ regulatory proteins. Cell Biochem Biophys. 2005;42(1):1\u201312.","journal-title":"Cell Biochem Biophys"},{"issue":"2","key":"460_CR25","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.yjmcc.2011.05.012","volume":"51","author":"Y Fang","year":"2011","unstructured":"Fang Y, et al. Improvement of left ventricular diastolic function induced by beta-blockade: a comparison between nebivolol and metoprolol. J Mol Cell Cardiol. 2011;51(2):168\u201376.","journal-title":"J Mol Cell Cardiol"},{"issue":"7","key":"460_CR26","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.jash.2015.03.009","volume":"9","author":"JL Izzo Jr","year":"2015","unstructured":"Izzo JL Jr, et al. Ambulatory 24-hour cardiac oxygen consumption and blood pressure-heart rate variability: effects of nebivolol and valsartan alone and in combination. J Am Soc Hypertens. 2015;9(7):526\u201335.","journal-title":"J Am Soc Hypertens"},{"issue":"2","key":"460_CR27","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1097\/HJH.0000000000001891","volume":"37","author":"A Bikos","year":"2019","unstructured":"Bikos A, et al. The effects of nebivolol and irbesartan on postdialysis and ambulatory blood pressure in patients with intradialytic hypertension: a randomized cross-over study. J Hypertens. 2019;37(2):432\u201342.","journal-title":"J Hypertens"}],"container-title":["BMC Pharmacology and Toxicology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40360-020-00460-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s40360-020-00460-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40360-020-00460-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,2]],"date-time":"2020-12-02T22:20:48Z","timestamp":1606947648000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpharmacoltoxicol.biomedcentral.com\/articles\/10.1186\/s40360-020-00460-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["460"],"URL":"https:\/\/doi.org\/10.1186\/s40360-020-00460-z","relation":{},"ISSN":["2050-6511"],"issn-type":[{"type":"electronic","value":"2050-6511"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"14 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The experiment was approved by the Medical Ethics Committee of Lanzhou University Second Hospital. All animal experiments were carried out in accordance with Guidelines for Ethical Review of Laboratory Animal Welfare of China.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"84"}}